781 related articles for article (PubMed ID: 27726962)
1. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
2. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
[TBL] [Abstract][Full Text] [Related]
6. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
10. Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea.
Kim SW; Kang GW
J Korean Med Sci; 2015 Dec; 30(12):1723-32. PubMed ID: 26713046
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
12. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
[TBL] [Abstract][Full Text] [Related]
13. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
Can J Ophthalmol; 2016 Dec; 51(6):467-470. PubMed ID: 27938959
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Screen for Diabetic Retinopathy in Chinese Patients with Newly Diagnosed Type 2 Diabetes: A Cost-Effectiveness Analysis.
Wu B; Li J; Wu H
Medicine (Baltimore); 2015 Nov; 94(45):e1989. PubMed ID: 26559285
[TBL] [Abstract][Full Text] [Related]
15. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
[No Abstract] [Full Text] [Related]
16. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
17. Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore's perspective on a global model.
Nguyen HV; Bose S; Mital S; Yii ACA; Ang SY; Lam SSW; Anantham D; Finkelstein E; Koh MS
Respirology; 2017 Aug; 22(6):1102-1109. PubMed ID: 28370985
[TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
[TBL] [Abstract][Full Text] [Related]
19. Telehealth Screening for Diabetic Retinopathy: Economic Modeling Reveals Cost Savings.
Curran DM; Kim BY; Withers N; Shepard DS; Brady CJ
Telemed J E Health; 2022 Sep; 28(9):1300-1308. PubMed ID: 35073213
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling.
Dorali P; Shahmoradi Z; Weng CY; Lee T
Ophthalmol Retina; 2023 Jun; 7(6):532-542. PubMed ID: 36621610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
